Sunday, July 07, 2024 4:15:17 PM
https://www.medicaldevice-developments.com/news/fdas-cber-approves-final-labelling-of-seastar-medicals-quelimmune-scd/
Recent ICU News
- Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial • GlobeNewswire Inc. • 11/01/2024 12:30:00 PM
- SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE • GlobeNewswire Inc. • 10/31/2024 12:30:00 PM
- Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 - Update • GlobeNewswire Inc. • 10/25/2024 03:32:00 PM
- Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 • GlobeNewswire Inc. • 10/25/2024 12:30:00 PM
- SeaStar Medical Announces that Stanford Medicine is Cleared to Actively Enroll Subjects in the Adult Acute Kidney Injury Pivotal Trial • GlobeNewswire Inc. • 10/23/2024 12:30:00 PM
- SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers • GlobeNewswire Inc. • 10/22/2024 12:30:00 PM
- SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis • GlobeNewswire Inc. • 10/18/2024 12:30:00 PM
- SeaStar Medical to Showcase New Mechanistic Data Highlighting the Immunomodulatory Effect of the Selective Cytopheretic Device in Acute Kidney Injury at ASN Kidney Week • GlobeNewswire Inc. • 10/15/2024 12:30:00 PM
- SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit • GlobeNewswire Inc. • 10/09/2024 12:30:00 PM
- SeaStar Medical Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities • GlobeNewswire Inc. • 10/08/2024 12:30:00 PM
- SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial • GlobeNewswire Inc. • 09/25/2024 12:30:00 PM
- SeaStar Medical to Webcast Fireside Chat at the H.C. Wainwright Global Investment Conference • GlobeNewswire Inc. • 09/05/2024 12:00:00 PM
- September 6, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against ICU • PR Newswire (US) • 09/05/2024 09:45:00 AM
- SeaStar Medical Strengthens Financial Position with Elimination of All Long-Term Debt • GlobeNewswire Inc. • 09/04/2024 12:30:00 PM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of SeaStar Medical Holding Corporation(ICU) Shareholders • PR Newswire (US) • 08/29/2024 09:45:00 AM
- Shareholders that lost money on SeaStar Medical Holding Corporation(ICU) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 08/26/2024 09:45:00 AM
- SeaStar Medical Holding Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before September 6, 2024 to Discuss Your Rights - ICU • PR Newswire (US) • 08/22/2024 09:45:00 AM
- Shareholders of SeaStar Medical Holding Corporation Should Contact The Gross Law Firm Before September 6, 2024 to Discuss Your Rights - ICU • PR Newswire (US) • 08/19/2024 09:45:00 AM
- SeaStar Medical Holding Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before September 6, 2024 to Discuss Your Rights - ICU • PR Newswire (US) • 08/15/2024 09:45:00 AM
- SeaStar Medical Reports Second Quarter 2024 Financial Results and Provides a Business Update • GlobeNewswire Inc. • 08/13/2024 08:38:00 PM
- The Gross Law Firm Notifies SeaStar Medical Holding Corporation Investors of a Class Action Lawsuit and Upcoming Deadline • PR Newswire (US) • 08/08/2024 09:45:00 AM
- Class Action Filed Against SeaStar Medical Holding Corporation (ICU) Seeking Recovery for Investors - Contact The Gross Law Firm • PR Newswire (US) • 08/05/2024 09:45:00 AM
- Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’s • GlobeNewswire Inc. • 07/26/2024 01:00:00 PM
- First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s FDA-Approved QUELIMMUNE Therapeutic Device • GlobeNewswire Inc. • 07/23/2024 12:30:00 PM
- Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s • GlobeNewswire Inc. • 07/17/2024 01:00:00 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM